1Life Healthcare Inc. (ONEM): Here Are Some Research Recommendations

0
14
RTX Stock
RTX Stock

1Life Healthcare Inc. (NASDAQ:ONEM) finished Wednesday with a subtraction of $0.0 to close at $17.13, a downside of 0.00 percent. An average of 3,154,080 shares of common stock have been traded in the last five days. There was a fall of -$0.07 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 3,295,580 shares traded, while the 50-day average volume stands at 6,149,354.

ONEM stock has decreased by -1.44% in the last month. The company shares reached their 1-month lowest point of $16.93 on 09/06/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $5.94 and a high of $25.47 in 52 weeks. It has reached a new high 2 times so far this year and lost -2.50% or -$0.44 in price. In spite of this, the price is down -32.74% from the 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored


Insider Transactions

38 days have passed since 1Life Healthcare Inc. (ONEM) last reported insider trading activity. Agarwal Vikas, who is Chief Accounting Officer, most recently acquired $394 shares at $17.14 per share on Aug 15.

Valuation Metrics

1Life Healthcare Inc. (ONEM) has a trailing price-to-sales (P/S) ratio at 3.75, the price-to-book (PB) ratio at 2.05.

Financial Health

The quick ratio of 1Life Healthcare Inc. for the three months ended June 29 was 2.60, and the current ratio was 2.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.19 and a total debt to equity ratio of 0.19 for the quarter ending June 29. Its gross profit as reported stood at $188.13 million compared to revenue of $623.32 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, 1Life Healthcare Inc.’s return on assets was -13.70%.

Earnings Surprise

For the three-month period that ended June 29, 1Life Healthcare Inc. had $162.87 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$93.81 million in the quarter, while revenues were grew 55.99%. The analyst consensus anticipated 1Life Healthcare Inc.’s latest quarter earnings to come in at -$0.48 per share, but it turned out to be -$0.48, a 0.00% surprise. For the quarter, EBITDA amounted to -$67.05 million. Shareholders own equity worth $195.18 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at 1Life Healthcare Inc. (ONEM) price momentum. RSI 9-day as of the close on 21 September was 51.40%, suggesting the stock is Neutral, with historical volatility in this time frame at 9.62%.

As of today, ONEM’s price is $17.11 -0.41% or -$0.07 from its 5-day moving average. ONEM is currently trading -1.83% lower than its 20-day SMA and +125.39% higher than its 100-day SMA. However, the stock’s current price level is +73.73% above the SMA50 and +10.95% above the SMA200.

The stochastic %K and %D were 35.79% and 34.03%, respectively, and the average true range (ATR) was 0.19. With the 14-day stochastic at 42.10% and the average true range at 0.23, the RSI (14) stands at 58.17%. The stock has reached 0.00 on the 9-day MACD Oscillator while the 14-day reading was at -0.04.

Analyst Ratings

Deutsche Bank downgraded 1Life Healthcare Inc. (NASDAQ: ONEM) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for 1Life Healthcare Inc. (ONEM) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ONEM, while 13 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.

What is ONEM’s price target for the next 12 months?

Analysts predict a range of price targets between $16.90 and $18.00, with a median target of $18.00. Taking a look at these predictions, the average price target given by analysts for 1Life Healthcare Inc. (ONEM) stock is $17.91.

LEAVE A REPLY

Please enter your comment!
Please enter your name here